Clinical trials
Glaucoma trials with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
507 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2002 | 1 |
| 2003 | 2 |
| 2004 | 4 |
| 2005 | 11 |
| 2006 | 7 |
| 2007 | 9 |
| 2008 | 6 |
| 2009 | 13 |
| 2010 | 17 |
| 2011 | 24 |
| 2012 | 16 |
| 2013 | 17 |
| 2014 | 26 |
| 2015 | 16 |
| 2016 | 25 |
| 2017 | 24 |
| 2018 | 31 |
| 2019 | 22 |
| 2020 | 31 |
| 2021 | 32 |
| 2022 | 32 |
| 2023 | 38 |
| 2024 | 19 |
| 2025 | 32 |
| 2026 | 39 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 257 |
| Unknown status | 107 |
| Recruiting | 64 |
| Terminated | 28 |
| Not yet recruiting | 20 |
| Withdrawn | 16 |
| Active, not recruiting | 9 |
| Enrolling by invitation | 4 |
| Suspended | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Wills Eye | 18 |
| Duke University | 12 |
| Sensimed AG | 11 |
| University of California, San Francisco | 10 |
| Stanford University | 9 |
| Glaukos Corporation | 7 |
| Medical University of Vienna | 7 |
| Optos, PLC | 7 |
| Centre hospitalier de l'Université de Montréal (CHUM) | 6 |
| Johns Hopkins University | 6 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Glaucoma | 507 |
| Glaucoma, Open-Angle | 89 |
| Ocular Hypertension | 49 |
| Cataract | 38 |
| Diabetic Retinopathy | 22 |
| Macular Degeneration | 21 |
| Eye Diseases | 20 |
| Glaucoma, Angle-Closure | 12 |
| Vision Disorders | 10 |
| Retinitis Pigmentosa | 9 |
Trials
Showing 1 to 25 of 507. Each trial links to its page on Pharma Observatory.
407 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.